Company facts
- Headquarters
- Cambridge, Massachusetts
- Most recent report
- 8-K, filed Sep 24, 2026
- Incorporated
- Delaware
- Filings on record
- 50 filings
- On EDGAR
- CIK 2114044
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 2
News 5
Prospectuses and Registrations 6
- S-8 Registration statement for an employee plan May 4, 2026
- 424B4 Final prospectus for an offering May 1, 2026
- S-1/A Registration statement for an offering, amended Apr 30, 2026
- S-1/A Registration statement for an offering, amended Apr 28, 2026
- S-1/A Registration statement for an offering, amended Apr 27, 2026
- S-1 Registration statement for an offering Apr 10, 2026
Ownership 8 of 31
- 4 Insider reported a trade Sep 25, 2026
- 3 Insider reported their initial holding Sep 25, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 12, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 7, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 6, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 5, 2026
Other 6
- EFFECT Notice that a registration became effective Apr 30, 2026
- S-1MEF Apr 30, 2026
- CERT Exchange certified a listing Apr 30, 2026
- 8-A12B Registration of a security for exchange listing Apr 27, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Apr 2, 2026
- DRS Draft registration statement, submitted confidentially Feb 27, 2026
Everything here comes from Hemab Therapeutics Holdings, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.